南非年轻妇女艾滋病毒感染的自然控制:HPTN 068。

Q2 Medicine
HIV Clinical Trials Pub Date : 2018-10-01 Epub Date: 2018-12-06 DOI:10.1080/15284336.2018.1531534
Mariya V Sivay, Jessica M Fogel, Jing Wang, Yinfeng Zhang, Estelle Piwowar-Manning, William Clarke, Autumn Breaud, Joel Blankson, Erica L Hamilton, Kathleen Kahn, Amanda Selin, F Xavier Gomez-Olive, Catherine MacPhail, James P Hughes, Audrey Pettifor, Susan H Eshleman
{"title":"南非年轻妇女艾滋病毒感染的自然控制:HPTN 068。","authors":"Mariya V Sivay,&nbsp;Jessica M Fogel,&nbsp;Jing Wang,&nbsp;Yinfeng Zhang,&nbsp;Estelle Piwowar-Manning,&nbsp;William Clarke,&nbsp;Autumn Breaud,&nbsp;Joel Blankson,&nbsp;Erica L Hamilton,&nbsp;Kathleen Kahn,&nbsp;Amanda Selin,&nbsp;F Xavier Gomez-Olive,&nbsp;Catherine MacPhail,&nbsp;James P Hughes,&nbsp;Audrey Pettifor,&nbsp;Susan H Eshleman","doi":"10.1080/15284336.2018.1531534","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Some individuals control HIV replication without antiretroviral (ARV) therapy.</p><p><strong>Objective: </strong>To analyze viral suppression in young women in rural South Africa enrolled in a trial evaluating a behavioral intervention for HIV prevention.</p><p><strong>Methods: </strong>Plasma samples were obtained from women ages 13-24 (81 infected at enrollment, 164 seroconverters). ARV testing was performed using an assay that detects 20 ARV drugs. Women were classified as viremic controllers if they were virally suppressed for ≥12 months with no ARV drug use.</p><p><strong>Results: </strong>Samples from 216/245 (88.2%) women had no ARV drugs detected at their first HIV-positive visit. Thirty-four (15.7%) of the 216 women had a viral load <2,000 copies/mL. Fifteen of the 34 women were followed for ≥12 months; 12 were virally suppressed with no ARV drugs detected during follow-up. These women were classified as viremic controllers (overall: 12/216 = 5.6%). The median CD4 cell count at the first HIV-positive visit was higher among the 12 controllers than among the 204 women who were not using ARV drugs (759 vs. 549 cells/mm<sup>3</sup>, p = 0.02). Some women had a viral load <40 copies/mL at a single study visit, but none were classified as elite controllers (viral load <40 copies/mL for ≥12 months with no ARV drug use).</p><p><strong>Conclusions: </strong>In this cohort, 5.6% of women who were not using ARV drugs had sustained viral suppression. This represents a minimum estimate of the frequency of viremic controllers in this cohort, since some women were not followed long enough to meet the criteria for classification.</p>","PeriodicalId":13216,"journal":{"name":"HIV Clinical Trials","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2018-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/15284336.2018.1531534","citationCount":"6","resultStr":"{\"title\":\"Natural control of HIV infection in young women in South Africa: HPTN 068.\",\"authors\":\"Mariya V Sivay,&nbsp;Jessica M Fogel,&nbsp;Jing Wang,&nbsp;Yinfeng Zhang,&nbsp;Estelle Piwowar-Manning,&nbsp;William Clarke,&nbsp;Autumn Breaud,&nbsp;Joel Blankson,&nbsp;Erica L Hamilton,&nbsp;Kathleen Kahn,&nbsp;Amanda Selin,&nbsp;F Xavier Gomez-Olive,&nbsp;Catherine MacPhail,&nbsp;James P Hughes,&nbsp;Audrey Pettifor,&nbsp;Susan H Eshleman\",\"doi\":\"10.1080/15284336.2018.1531534\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Some individuals control HIV replication without antiretroviral (ARV) therapy.</p><p><strong>Objective: </strong>To analyze viral suppression in young women in rural South Africa enrolled in a trial evaluating a behavioral intervention for HIV prevention.</p><p><strong>Methods: </strong>Plasma samples were obtained from women ages 13-24 (81 infected at enrollment, 164 seroconverters). ARV testing was performed using an assay that detects 20 ARV drugs. Women were classified as viremic controllers if they were virally suppressed for ≥12 months with no ARV drug use.</p><p><strong>Results: </strong>Samples from 216/245 (88.2%) women had no ARV drugs detected at their first HIV-positive visit. Thirty-four (15.7%) of the 216 women had a viral load <2,000 copies/mL. Fifteen of the 34 women were followed for ≥12 months; 12 were virally suppressed with no ARV drugs detected during follow-up. These women were classified as viremic controllers (overall: 12/216 = 5.6%). The median CD4 cell count at the first HIV-positive visit was higher among the 12 controllers than among the 204 women who were not using ARV drugs (759 vs. 549 cells/mm<sup>3</sup>, p = 0.02). Some women had a viral load <40 copies/mL at a single study visit, but none were classified as elite controllers (viral load <40 copies/mL for ≥12 months with no ARV drug use).</p><p><strong>Conclusions: </strong>In this cohort, 5.6% of women who were not using ARV drugs had sustained viral suppression. This represents a minimum estimate of the frequency of viremic controllers in this cohort, since some women were not followed long enough to meet the criteria for classification.</p>\",\"PeriodicalId\":13216,\"journal\":{\"name\":\"HIV Clinical Trials\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.1080/15284336.2018.1531534\",\"citationCount\":\"6\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"HIV Clinical Trials\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1080/15284336.2018.1531534\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/12/6 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q2\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"HIV Clinical Trials","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15284336.2018.1531534","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/12/6 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 6

摘要

背景:一些个体在没有抗逆转录病毒(ARV)治疗的情况下控制HIV复制。目的:分析南非农村参加一项评估艾滋病预防行为干预试验的年轻妇女的病毒抑制情况。方法:采集13-24岁女性的血浆样本(入组时感染81例,转化者164例)。使用一种检测20种抗逆转录病毒药物的检测方法进行抗逆转录病毒检测。如果女性在没有使用抗逆转录病毒药物的情况下病毒抑制≥12个月,则被归类为病毒控制者。结果:216/245例(88.2%)妇女在首次hiv阳性就诊时未检出抗逆转录病毒药物。216名妇女中34名(15.7%)有病毒载量,p = 0.02)。结论:在该队列中,5.6%未使用抗逆转录病毒药物的妇女持续病毒抑制。这代表了该队列中病毒病毒控制者频率的最低估计,因为一些妇女随访时间不够长,无法达到分类标准。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Natural control of HIV infection in young women in South Africa: HPTN 068.

Natural control of HIV infection in young women in South Africa: HPTN 068.

Background: Some individuals control HIV replication without antiretroviral (ARV) therapy.

Objective: To analyze viral suppression in young women in rural South Africa enrolled in a trial evaluating a behavioral intervention for HIV prevention.

Methods: Plasma samples were obtained from women ages 13-24 (81 infected at enrollment, 164 seroconverters). ARV testing was performed using an assay that detects 20 ARV drugs. Women were classified as viremic controllers if they were virally suppressed for ≥12 months with no ARV drug use.

Results: Samples from 216/245 (88.2%) women had no ARV drugs detected at their first HIV-positive visit. Thirty-four (15.7%) of the 216 women had a viral load <2,000 copies/mL. Fifteen of the 34 women were followed for ≥12 months; 12 were virally suppressed with no ARV drugs detected during follow-up. These women were classified as viremic controllers (overall: 12/216 = 5.6%). The median CD4 cell count at the first HIV-positive visit was higher among the 12 controllers than among the 204 women who were not using ARV drugs (759 vs. 549 cells/mm3, p = 0.02). Some women had a viral load <40 copies/mL at a single study visit, but none were classified as elite controllers (viral load <40 copies/mL for ≥12 months with no ARV drug use).

Conclusions: In this cohort, 5.6% of women who were not using ARV drugs had sustained viral suppression. This represents a minimum estimate of the frequency of viremic controllers in this cohort, since some women were not followed long enough to meet the criteria for classification.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
HIV Clinical Trials
HIV Clinical Trials 医学-传染病学
CiteScore
1.76
自引率
0.00%
发文量
0
审稿时长
>12 weeks
期刊介绍: HIV Clinical Trials is devoted exclusively to presenting information on the latest developments in HIV/AIDS clinical research. This journal enables readers to obtain the most up-to-date, innovative research from around the world.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信